Found 8 matching trials
Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer PHASE2 The study is being conducted to evaluate the efficacy, safety and tolerabil...
Show More Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi PHASE2 This is a randomized, multicenter, two-arm, noncomparative, phase II study ...
Show More Location
Affiliated Tumor Hospital of Guangxi Medical University.
Learn More & Join Trial
A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects. PHASE1 The primary objective of the study was to assess investigate the pharmacoki...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma PHASE1 In advanced osteosarcoma where traditional chemotherapy has failed, the mul...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma PHASE2 This is a prospective, non-randomized, open-label, single-center phase II c...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma PHASE2 Adrenocortical carcinoma (ACC) is a rare aggressive malignant tumor. Accord...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
A Food Effect Study of Apatinib Mesylate in Healthy Subjects PHASE1 The primary objective of the study was to assess the effect of high-fat and...
Show More Location
Beijing Luhe Hospital, Capital Medical University
Learn More & Join Trial
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 PHASE3 The purpose of this study is to measure the efficacy and safety of AZD0901 ...
Show More Status
Active Not Recruiting
Learn More & Join Trial